Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2026-01-04 @ 1:03 PM
Study NCT ID:
NCT02237157
Status:
COMPLETED
Last Update Posted:
2021-05-07
First Post:
2014-09-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer
Sponsor:
RenovoRx
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-03
Start Date Type:
None
Primary Completion Date:
2016-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-09
Completion Date Type:
ACTUAL
First Submit Date:
2014-09-08
First Submit QC Date:
None
Study First Post Date:
2014-09-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-12-06
Results First Submit QC Date:
None
Results First Post Date:
2021-05-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-14
Last Update Post Date:
2021-05-07
Last Update Post Date Type:
ACTUAL